| Flotillin-2 | |
|---|---|
| Protein Name | Flotillin-2 |
| Gene Symbol | [FLOT2](/genes/flot2) |
| UniProt ID | [Q14244](https://www.uniprot.org/uniprot/Q14244) |
| PDB Structures | 2MAU, 2MOV |
| Molecular Weight | 43 kDa |
| Subcellular Localization | Membrane rafts, Cytoplasm, Endosomes |
| Protein Family | Flotillin/Reggie family |
| Tissue Expression | Brain, Lung, Kidney, Skin |
Flotillin-2 (also known as Reggie-1) is a 43 kDa integral membrane protein belonging to the flotillin family of lipid raft-associated scaffold proteins. Along with its paralog flotillin-1, flotillin-2 organizes lipid raft microdomains and participates in various cellular processes including signal transduction, membrane trafficking, cell adhesion, and neurotransmitter release. In the nervous system, flotillin-2 is expressed in neurons and glial cells where it regulates synaptic function, axonal guidance, and has been increasingly implicated in neurodegenerative processes including Alzheimer's Disease and Parkinson's Disease.
Flotillin proteins were originally identified in neurons as proteins rapidly upregulated during optic nerve regeneration, leading to their initial characterization as "reggie" (regeneration-associated proteins). Subsequent research revealed their fundamental role in organizing lipid raft microdomains and serving as scaffolds for various signaling molecules.
Flotillin-2 is a member of the stomatin/prohibitin/flotillin/HflC/K (SPFH) protein family, characterized by a conserved SPFH domain (stomatin/prohibitin/flotillin/HflC/K) located at the N-terminus. The SPFH domain mediates protein-protein interactions and serves as a platform for assembling signaling complexes. Flotillin-2 forms hetero-oligomeric complexes with flotillin-1 through interactions mediated by this domain.
The protein contains:
Flotillin-2 localizes predominantly to lipid rafts—cholesterol- and sphingolipid-rich microdomains that serve as signaling platforms in the plasma membrane. The protein also associates with intracellular compartments including endosomes and the trans-Golgi network.
Flotillin-2 plays a critical role in organizing lipid raft microdomains, which are essential for efficient signal transduction in neurons. Lipid rafts concentrate signaling receptors, G proteins, and downstream effectors, facilitating rapid and specific signal transmission. Flotillin-2 acts as a scaffold, clustering these signaling molecules and modulating their activity.
In the nervous system, flotillin-2 is enriched at synapses where it participates in:
Flotillin-2 serves as a platform for multiple signaling pathways:
Flotillin-2 has been increasingly implicated in Alzheimer's Disease pathogenesis:
Amyloid-beta interactions: Flotillin-2 localizes with amyloid-beta plaques in AD brain tissue. Studies show that flotillin-2 expression is altered in proximity to amyloid deposits, suggesting involvement in amyloid metabolism or response to amyloid toxicity.
Lipid raft dysfunction: AD is associated with disrupted lipid raft organization. Flotillin-2, as a key lipid raft component, may contribute to or result from raft dysregulation. Changes in flotillin-2 expression affect amyloid precursor protein (APP) processing and amyloid-beta generation.
Tau pathology: Flotillin-2 has been shown to interact with tau protein and may influence tau phosphorylation and aggregation. The protein's role in membrane trafficking may affect tau clearance mechanisms.
Synaptic dysfunction: Flotillin-2's critical role in synaptic function makes it vulnerable in AD. Altered flotillin-2 expression contributes to synaptic loss and dysfunction characteristic of AD.
In Parkinson's Disease, flotillin-2 participates in:
Dopaminergic neuron survival: Flotillin-2 expression is altered in PD brain regions, particularly in the substantia nigra. The protein may protect dopaminergic neurons from oxidative stress.
Alpha-synuclein aggregation: Flotillin-2 has been shown to interact with alpha-synuclein and may influence its aggregation and clearance. Lipid raft alterations may affect alpha-synuclein membrane binding.
Mitochondrial function: Flotillin-2 participates in mitochondrial quality control pathways that are disrupted in PD.
Flotillin-2 represents a potential therapeutic target for neurodegenerative diseases:
Flotillin-2 interacts with numerous proteins involved in neurodegeneration: